Article Details

Alkermes Announces Commercial Availability of LYBALVI® for the Treatment of Schizophrenia and ...

Retrieved on: 2021-10-19 20:03:08

Tags for this article:

Click the tags to see associated articles and topics

Alkermes Announces Commercial Availability of LYBALVI® for the Treatment of Schizophrenia and .... View article details on hiswai:

Excerpt

Potential for Cognitive and Motor Impairment: Because LYBALVI may cause ... innovative medicines in the fields of neuroscience and oncology.

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up